Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $9.36, but opened at $9.71. Gyre Therapeutics shares last traded at $10.23, with a volume of 5,966 shares.
Gyre Therapeutics Stock Up 20.6 %
The firm has a 50 day moving average price of $12.86 and a 200 day moving average price of $16.87.
Gyre Therapeutics (NASDAQ:GYRE – Get Free Report) last issued its earnings results on Thursday, May 9th. The company reported $0.04 earnings per share for the quarter. The firm had revenue of $27.17 million during the quarter. As a group, research analysts anticipate that Gyre Therapeutics, Inc. will post -0.45 earnings per share for the current fiscal year.
Insider Buying and Selling
Gyre Therapeutics Company Profile
Gyre Therapeutics, Inc, a biopharmaceutical company, primarily focuses on the development and commercialization of Hydronidone for the treatment of Metabolic Dysfunction Associated Steatohepatitis in the United States. Its Hydronidone is also being evaluated for the treatment of liver fibrosis across a spectrum of chronic liver diseases.
Read More
- Five stocks we like better than Gyre Therapeutics
- How to Invest in Biotech Stocks
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- How to Buy Cheap Stocks Step by Step
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Investing in Construction Stocks
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Gyre Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyre Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.